Current landscape of phenylketonuria in Colombia

Main Article Content

Ana Maria Zarante
Sandra Milena Navarro Marroquín
Juan Carlos Prieto
Lissete Cabarcas Castro
Marvid Sol Duarte Moreno
Oscar Mauricio Espitia Segura
Ignacio Zarante
Luz Helena Castaño Torres
Sandra Catalina Mesa Restrepo
Carolina Baquero
Sandra Ospina Lagos

Abstract

Background: Phenylketonuria (PKU) is an inborn error of hepatic phenylalanine (Phe) metabolism. Chronic Phe accumulation is deleterious to the central nervous system, as it causes cognitive impairment and severe behavioral disturbance.


Topic: Early diagnosis through neonatal screening is pivotal as it allows for modifying the disease's natural course and offers timely genetic counseling.


Conclusions: We aim to review the current overview of the disease and neonatal screening in Colombia, while approaching the challenges in therapy and follow-up of early and late-diagnosed patients.

Downloads

Download data is not yet available.

Article Details

How to Cite
Zarante , A. M., Navarro Marroquín, S. M., Prieto, J. C., Cabarcas Castro, L., Duarte Moreno, M. S., Espitia Segura, O. M., … Ospina Lagos, S. (2024). Current landscape of phenylketonuria in Colombia. Pediatría, 57(2), e494. https://doi.org/10.14295/rp.v57i2.494
Section
Opinion article
Author Biography

Ana Maria Zarante , Hospital Universitario San Ignacio

Genetista clinico y Genetista de la Clinica de Errores innatos del metabolismo del Hospital Universitario San Ignacio

References

Rovelli, V. & Longo, N. Phenylketonuria and the brain. Mol. Genet. Metab. 107583 (2023).

https://doi.org/10.1016/j.ymgme.2023.107583

Van Spronsen et al. Phenylketonuria. Nat. Rev. Dis. Primer 7, 36 (2021).

https://doi.org/10.1038/s41572-021-00267-0

Grupo de trabajo de protocolos de cribado neonatal. Protocolo de cribado de fenilcetonuria. (2021).

Van Spronsen. et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 5, 743-756 (2017).

https://doi.org/10.1016/S2213-8587(16)30320-5

Pessoa, A. L. S. et al. Burden of phenylketonuria in Latin American patients. Orphanet J. Rare Dis. 17, 302 (2022).

https://doi.org/10.1186/s13023-022-02450-2

Borrajo, G. J. Newborn screening for phenylketonuria: Latin American consensus guidelines. J. Inborn Errors Metab. Screen. 4, (2019).

https://doi.org/10.1177/2326409816682764

Hillert, A. et al. The Genetic Landscape and Epidemiology of Phenylketonuria. Am. J. Hum. Genet. 107, 234-250 (2020).

https://doi.org/10.1016/j.ajhg.2020.06.006

García-Restrepo, N. y colaboradores. Deficiencia de fenilalanina hidroxilasa: espectro clínico y estado actual en Colombia. Biosalud 49-64 (2018).

https://doi.org/10.17151/biosa.2018.17.1.6

Instituto Nacional de Salud & Ministerio de Salud y Protección Social. Informe de evento ENFERMEDADES HUÉRFANAS -RARAS. A periodo epidemiológico VI de 2023.

Escaf, M. Fenilcetonuria e hiperfenilalaninemia en recién nacidos. Salud Uninorte 36-39 (2003).

Barboza, M., Alvear, C., y col. Encefalopatía epiléptica por fenilcetonuria. Acta Neurol Colomb 22, (2006).

Gélvez, N. et al. Caracterización fenotípica y molecular de familia colombiana con fenilcet. Biomédica 36, 390-396 (2016).

https://doi.org/10.7705/biomedica.v36i3.2639

Giugliani, R. et al. Opportunities and challenges for newborn screening and early diagnosis in Latin America. Front. Genet. 13, 1053559 (2022).

https://doi.org/10.3389/fgene.2022.1053559

Borrajo, G. J. Newborn screening in Latin America: A brief overview of the state of the art. in vol. 187 322-328 (Wiley Online Library, 2021).

https://doi.org/10.1002/ajmg.c.31899

Cabello, J & Colombo, M. Expanded newborn screening and genomic sequencing in Latin America and the resulting social justice and ethical considerations. Int. J. Neonatal Screen. 7, 6 (2021).

https://doi.org/10.3390/ijns7010006

Ministerio de Salud y Protección Social. Ley 1980 de 2019.

Instituto Nacional de Salud. Protocolo de Vigilancia de Defectos Congénitos Código 215. (2023).

Instituto Nacional de Salud. Protocolo de Vigilancia de Enfermedades Huérfanas Código 342. (2022).

Van Wegberg, A. et al. The complete European guidelines on phenylketonuria. Orphanet J. Rare Dis. 12, 1-56 (2017).

https://doi.org/10.1186/s13023-017-0685-2

Echeverri, O. Y. et al. Research, diagnosis and education in inborn errors of metabolism in Colombia. Orphanet J. Rare Dis. 13, 1-12 (2018).

https://doi.org/10.1186/s13023-018-0879-2

Van Vliet, D. et al. Can untreated PKU patients escape from intellectual disability. Systematic review. Orphanet J. Rare Dis. 13, 149 (2018).

https://doi.org/10.1186/s13023-018-0890-7

Kenneson, A. et al. Natural history of children and adults with phenylketonuria in the NBS-PKU. Mol. Genet. Metab. 134, 243-249 (2021).

https://doi.org/10.1016/j.ymgme.2021.10.001

Poloni, S. et al. Current practices and challenges in the diagnosis and management of PKU in Latin America. Nutrients 13, 2566 (2021).

https://doi.org/10.3390/nu13082566

EMA. Kuvan. European Medicines Agency https://www.ema.europa.eu/en/medicines/human/EPAR/kuvan (2018).

Anjema, K. et al. Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype. Orphanet J. Rare Dis. 8, 103 (2013).

https://doi.org/10.1186/1750-1172-8-103

Instituto Nacional de Vigilancia de Medicamentos y Alimentos INVIMA.

Qu, J. et al. Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria. Br. J. Clin. Pharmacol. 85, 893-899 (2019).

https://doi.org/10.1111/bcp.13886

Waisbren, S. et al. Long-term preservation of intellectual functioning in sapropterin-treated infants and young children with phenylketonuria. Mol. Genet. Metab. 132, 119-127 (2021).

https://doi.org/10.1016/j.ymgme.2021.01.001

Ilgaz, F. et al. Protein substitute requirements of patients with phenylketonuria on BH4 treatment. Nutrients 13, 1040 (2021).

https://doi.org/10.3390/nu13031040

Muntau, A. C. et al. International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria. Mol. Genet. Metab. 127, 1-11 (2019).

https://doi.org/10.1016/j.ymgme.2019.04.004

Most read articles by the same author(s)

Similar Articles

<< < 4 5 6 7 8 9 10 11 12 13 > >> 

You may also start an advanced similarity search for this article.